Strategic Communications hosts Vista Pavilion media availability/tour with Shereef Elnahal, M.D., M.B.A., and Brian Druker, M.D., before the April 7 opening. Druker says, “I can't tell you how many times we've had patients who need services here at OHSU, Knight Cancer Institute, who are in hospitals around the state waiting to be transferred and have to wait days to weeks to get here. With the opening of the Vista Pavilion, 128 new beds online, we're going to be able to bring those patients that need that critical care here immediately."

Strategic Communications hosts Vista Pavilion media availability/tour with Shereef Elnahal, M.D., M.B.A., and Brian Druker, M.D., before the April 7 opening. Druker says, “I can't tell you how many times we've had patients who need services here at OHSU, Knight Cancer Institute, who are in hospitals around the state waiting to be transferred and have to wait days to weeks to get here. With the opening of the Vista Pavilion, 128 new beds online, we're going to be able to bring those patients that need that critical care here immediately."

An article in Lifestyles Magazine on Phil and Penny Knight's $75 million gift for cardiac care at Providence Heart Institute and Providence St. Vincent Medical Center mentions their historic $2 billion pledge to OHSU’s Knight Cancer Institute, announced in August 2025.

Hagen Kennecke, M.D., reviews several studies guiding systemic therapy in advanced neuroendocrine tumors and shares how clinical trials have reshaped care with targeted medications everolimus and PRRT, or peptide receptor radionuclide therapy.

The National Institute on Drug Abuse of the National Institutes of Health awards OHSU researchers and other organizations $3.3 million to assess the safety and effectiveness of state-regulated access to psilocybin, also known as magic mushrooms; Adie Rae, Ph.D. says, “This is the first federally funded work to study the impact of legal psychedelic services delivered in community settings. There is an urgent need to assess the safety of these programs and their impact on substance use before more voters and policymakers are asked to consider their merits and drawbacks.”

The National Institute on Drug Abuse of the National Institutes of Health awards OHSU researchers and other organizations $3.3 million to assess the safety and effectiveness of state-regulated access to psilocybin, also known as magic mushrooms; Adie Rae, Ph.D. says, “This is the first federally funded work to study the impact of legal psychedelic services delivered in community settings. There is an urgent need to assess the safety of these programs and their impact on substance use before more voters and policymakers are asked to consider their merits and drawbacks.”

Kara Connelly, M.D., provides testimony to the Oregon Legislature about doxing and death threats members of the Doernbecher Gender Clinic have faced over the past few years in the context of House Bill 4088, which would enhance Oregon’s shield laws safeguarding clinicians’ liability insurance and personal information, and protect them from out-of-state prosecutions, investigations and professional discipline; Connelly says, “Specialty clinics at other institutions in Oregon have removed their websites entirely, causing confusion for Oregonians about which programs remain open and resulting in an influx of new referrals to our program which we do not have the capacity to take on.”

Wendy Smith, M.D., participates in an Investigate West panel on how Oregon can improve its support for pregnant people with substance abuse challenges who are most vulnerable to poor outcomes; Smith says, “It’s a period where people experience differences that can lead to better outcomes, and we’ve gotta take advantage of it.”

Yahoo! news covers an OHSU study that identified disturbing impacts of air pollutants on children’s developing brains.

Jeff Gold, M.D., is among eight experts who have “teamed up with technology and patient and caregiver safety leaders to set guidelines for patient communications involving AI.”